Cargando…
Preclinical efficacy investigation of human neutrophil elastase inhibitor sivelestat in animal model of psoriasis
BACKGROUND: Psoriasis is a chronic immune‐mediated inflammatory skin disease manifested by an increased rate of keratinocyte division. Currently, it has been established that the cytokines of the IL‐36 family play a significant role in the initiation and regulation of the inflammatory process in pso...
Autores principales: | Zhukov, A. S., Khairutdinov, V. R., Samtsov, A. V., Krasavin, M., Garabadzhiu, A. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168022/ https://www.ncbi.nlm.nih.gov/pubmed/35677925 http://dx.doi.org/10.1002/ski2.90 |
Ejemplares similares
-
Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors
por: Crocetti, Letizia, et al.
Publicado: (2020) -
The neutrophil elastase inhibitor, sivelestat, attenuates sepsis-related kidney injury in rats
por: Li, Guofu, et al.
Publicado: (2016) -
Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndrome
por: Aikawa, Naoki, et al.
Publicado: (2014) -
The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass
por: Pan, Tuo, et al.
Publicado: (2023) -
Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis
por: Miyoshi, Seigo, et al.
Publicado: (2013)